Form 4: Avantor EVP Granted Significant Equity Awards

Avantor's EVP, Chief HR Officer, Brittany Hankamer, received substantial grants of restricted stock units and stock options, alongside a minor share disposition for tax purposes.

Summary

• Brittany Hankamer, EVP, Chief HR Officer of Avantor, Inc. (AVTR), reported changes in her beneficial ownership.
• On February 19, 2026, Hankamer was granted 80,618 shares of Common Stock in the form of restricted stock units (RSUs) at a price of $0 per share.
• These RSUs are scheduled to vest in three equal annual installments, commencing on February 19, 2027.
• Additionally, on February 19, 2026, Hankamer was granted 317,310 stock options with an exercise price of $11.05 per share.
• These stock options are also set to vest in three equal annual installments, beginning on February 19, 2027, and have an expiration date of February 19, 2036.
• On February 20, 2026, Hankamer disposed of 1,453 shares of Common Stock at a price of $9.03 per share, representing shares withheld by Avantor to cover tax withholding obligations related to the vesting of RSUs.
• Following these transactions, Hankamer beneficially owns 250,728 shares of Common Stock directly and 317,310 stock options directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as significant equity grants to a key executive typically signal confidence in the company's future and align management's interests with those of shareholders, although it does not reflect operational performance.

Positives

• The grant of 80,618 restricted stock units and 317,310 stock options aligns the executive's long-term interests with those of shareholders, incentivizing sustained company performance.
• Equity-based compensation is a standard practice to attract and retain key talent, signaling confidence in the executive's role and future contributions.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that executive equity grants are a common compensation practice across industries, designed to align management incentives with long-term shareholder value and encourage retention. This type of compensation structure is prevalent in the life sciences and technology sectors where Avantor operates.

Comparison to Industry Standards

• Executive compensation packages in the life sciences and technology sectors frequently incorporate a mix of restricted stock units and stock options, similar to this grant, to incentivize performance and retention.
• Companies like Thermo Fisher Scientific (TMO) and Danaher Corporation (DHR), which operate in related scientific and technology fields, often utilize comparable equity-based compensation structures for their senior executives to foster long-term commitment and align with shareholder interests.

Stakeholder Impact

• Shareholders: The equity grants align the interests of a key executive with shareholders, potentially leading to more focused long-term value creation.
• Employees: May signal stability and confidence in the company's leadership, potentially boosting morale.

Next Steps

• Vesting of restricted stock units in three equal annual installments beginning February 19, 2027.
• Vesting of stock options in three equal annual installments beginning February 19, 2027.

Key Dates

Recommendation

The equity grants to a key executive are a positive signal, aligning management's interests with shareholders and incentivizing long-term performance. However, this Form 4 filing alone does not provide new fundamental information about Avantor's business operations or financial performance to warrant a change in investment thesis, hence a 'hold' recommendation.

Keywords

Avantor, AVTR, Form 4, Insider Transaction, Equity Grant, Restricted Stock Units, Stock Options, Executive Compensation, Beneficial Ownership